Stem Cells and Good Manufacturing Practices

Swiss Fetal Transplantation Program and Non-Enzymatically Isolated Primary Progenitor Cell Types for Regenerative Medicine.- GMP Tiered Cell Banking of Non-Enzymatically Isolated Dermal Progenitor Fibroblasts for Allogenic Regenerative Medicine.- Progenitor Biological Bandages: An Authentic Swiss Tool for Safe Therapeutic Management of Burns, Ulcers, and Donor Site Grafts.- Validation of the Media Fill Method for Solid Tissue Processing in Good Manufacturing Practice-Compliant Cell Production.- The Isolation, Culturing, Cryopreservation, and the Preparation as a Final Cellular Product of the Umbilical Cord-Derived Mesenchymal Stem Cells Under Good Manufacturing Practices Conditions.- The Isolation, Culture, Cryopreservation, and the Preparation as a Final Cellular Product of the Skin-Derived Fibroblasts Under Good Manufacturing Practice Conditions.- The Isolation and Manufacture of GMP-Grade Bone Marrow Stromal Cells from Bone Specimens.- Scalable Manufacturing of Human Hematopoietic Stem/Progenitor Cells Exploiting a Co-Culture Platform with Mesenchymal Stromal Cells.- GMP-Compatible, Xeno-Free Culture of Human Induced Mesenchymal Stem Cells.- GMP-Grade Methods for Cardiac Progenitor Cells: Cell Bank Production and Quality Control.- Suspension Culture of Human Induced Pluripotent Stem Cells in Single-Use Vertical-WheelTM Bioreactors Using Aggregate and Microcarrier Culture Systems.- Addressing Manufacturing Challenges for Commercialization of iPSC-Based Therapies.- Standard Operating Procedure for the Good Manufacturing Practice-Compliant Production of Human Endometrial Stem Cells for Multiple Sclerosis.- GMP-Compliant Production of Human Placenta-Derived Mesenchymal Stem Cells.- GMP-Compliant Human Schwann Cells Manufacturing for Clinical Application.- GMP-Compliant Adenoviral Vectors for Gene Therapy.- Use of Multipotent Mesenchymal Stromal Cells, Fibrin, and Scaffolds in ihe Production of Clinical Grade Bone Tissue Engineering Products.- QualityManagement Systems (QMSs) of Human Tissue- and Cell-Based Product Manufacturing Facilities.